Giuseppe Battaglia Archives - Page 3 of 4 - Institute for Bioengineering of Catalonia

October 28, 2022June 14, 2022

Animal Lab technician

Application Deadline: 30/06/2022
Ref: LT_GB

The Molecular Bionics group at the Institute for Bioengineering of Catalonia (IBEC) led by Prof. Giuseppe Battaglia at the Institute for Bioengineering of Catalonia (IBEC) is looking for a laboratory technician to support the animal research lines of the biology section of the team, as well as to contribute to the general lab maintenance.

March 22, 2022January 19, 2022

Three IBEC researchers granted with “La Caixa Foundation” fellowships for young scientific leaders

Veronika Magdanz, of the Nano Intelligent Devices Group led by Samuel Sánchez, as well as Iris Batalha and Mohit Kumar of the Molecular Bionics group led by Giuseppe Battaglia, have … Read more

September 30, 2021September 30, 2021

IBEC researchers participate in the “European Researchers’ Night”

Last Friday, September 24, the “European Researchers’ Night” took place, an event that is held on a European scale in more than 300 cities in 30 different countries. The objective of this event is to publicize the diversity of science and its impact on the daily lives of citizens in a close and inspiring way. For yet another year, IBEC has not wanted to miss it and has been present at various activities.

December 15, 2020December 15, 2020

A mechanism to cross the blood-brain bareer has been discovered

Giuseppe Battaglia, leader of the IBEC “Molecular Bionics” group and ICREA Research Professor appears in various media for his recent study describing a mechanism and conditions that allow molecules to efficiently cross the blood-brain barrier, the protective layer of the brain.

April 22, 2021December 1, 2020

IBEC calls society to action to accelerate research against COVID19

The Institute for Bioengineering of Catalonia (IBEC) launches the Faster Future “A por la COVID19” campaign, with the aim of raising the 100.000€ needed to accelerate three research projects in collaboration with hospitals and patients associations.

December 11, 2020November 28, 2020

Researchers discover a mechanism to cross the protective barrier of the brain

An international study led by IBEC researcher Giuseppe Battaglia identifies a mechanism and conditions that allow molecules to efficiently cross the blood-brain barrier, the protective layer of the brain. This study describes the role of protein LRP1, bringing light to safe and efficient entrance of drugs to the brain.

September 28, 2020September 28, 2020

Imaginenano Online 2020

Imaginenano2020 Online Imaginenano2020 organisers have been closely monitoring global developments of the COVID-19 virus since the start of the year. The health and safety of our speakers, exhibitors, participants and … Read more

September 29, 2020September 25, 2020

Range selectivity, a new concept that could lead to more efficient nanoparticle drug delivery

In a new study published in the scientific journal Nature Communications, researchers describe a new concept called “range selectivity”, explaining why biomimetic nanoparticles only bind to receptors when their density is within a precise range.

This finding could pave the way for the development of highly targeted therapies against a number of diseases.

June 19, 2020June 19, 2020

Bioengineering against the most resistant and deadly bacterial infections

An international team, led by Profs Giuseppe Battaglia and Loris Rizzello from the Institute for Bioengineering of Catalonia (IBEC), carried out out a study that opens the door to a new therapy capable of quickly and effectively eliminating infections caused by intracellular bacteria, the most resistant to immune defenses.

This therapy, based on synthetic vesicles, could considerably reduce the dose and duration of antimicrobial treatments, thus reducing the danger of generating resistance to antibiotics of pathogens such as those leading to tuberculosis.

June 30, 2020June 19, 2020

A “faster and safer” therapy against tuberculosis

A team of international scientists led by the Institute for Bioengineering of Catalonia (IBEC) has developed a “faster, more effective and safer” therapy to eliminate infections of intracellular bacteria that cause diseases such as tuberculosis. Scientists participating in the study include Group Leader Giuseppe Battaglia and the researcher Loris Rizzello of IBEC.